Related references
Note: Only part of the references are listed.Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry
Khalid F. Alhabib et al.
PLOS ONE (2021)
Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a National Registry and Multicenter Cohort Study
Christine E. Haugen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
Ilse K. Luirink et al.
ATHEROSCLEROSIS (2020)
Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia The ORION-2 Pilot Study
G. Kees Hovingh et al.
CIRCULATION (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)-Long-Term Follow-Up of a Patient and Literature Review
Matej Mlinaric et al.
FRONTIERS IN PEDIATRICS (2020)
Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients
Mohammad Bilal Siddiqui et al.
HEPATOLOGY (2019)
Liver Transplantation for Homozygous Familial Hypercholesterolemia
Yasushi Ishigaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Management of dyslipidemia in adult solid organ transplant recipients
Bruce A. Warden et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
Meral Kayikcioglu et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation
Samarth S. Patel et al.
LIVER TRANSPLANTATION (2019)
Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectives
Ricardo Rodriguez-Calvo et al.
JOURNAL OF MEDICAL GENETICS (2019)
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
Meral Kayikcioglu et al.
ATHEROSCLEROSIS (2018)
Treatment-related and health-related quality of life in lipoprotein apheresis patients
V De Gucht et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
Dirk J. Blom et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
Ulf Landmesser et al.
EUROPEAN HEART JOURNAL (2017)
Rapidly progressive atherosclerosis after domino liver transplantation from a teenage donor with homozygous familial hypercholesterolemia
Jessica R. Golbus et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens
Sandra Habbig et al.
PEDIATRIC TRANSPLANTATION (2017)
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
Frederick J. Raal et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia
Mercedes Martinez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
Michael France et al.
ATHEROSCLEROSIS (2016)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
Barbara S. Wiggins et al.
CIRCULATION (2016)
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
Rodrigo Alonso et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Progressive Aortic Stenosis in Homozygous Familial Hypercholesterolemia After Liver Transplant
Margaret Greco et al.
PEDIATRICS (2016)
Lipids in liver transplant recipients
Anna Huesing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
Anthony Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Lipoprotein Apheresis
Patrick M. Moriarty et al.
CARDIOLOGY CLINICS (2015)
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
Abdullah Al-Ashwal et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Albert Wiegman et al.
EUROPEAN HEART JOURNAL (2015)
Evolution of Serum Atherogenic Risk in Liver Transplant Recipients: Role of Lipoproteins and Metabolic and Inflammatory Markers
Ravi Chhatrala et al.
LIVER TRANSPLANTATION (2015)
Liver transplantation as a definitive treatment for familial hypercholesterolemia: A series of 36 cases
Mohsenreza Mansoorian et al.
PEDIATRIC TRANSPLANTATION (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
Transmission of LDLR Mutation From Donor Through Liver Transplantation Resulting in Hypercholesterolemia in the Recipient
K. Nikkila et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Lipoprotein apheresis: State of the art and novelties
C. Stefanutti et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Marina Cuchel et al.
LANCET (2013)
Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
Asgeir Graesdal et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know
Siddharth Singh et al.
MAYO CLINIC PROCEEDINGS (2012)
Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Stephen R. Daniels et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be
J. F. Castroagudin et al.
TRANSPLANTATION PROCEEDINGS (2011)
Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study
K. D. S. Watt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
AA Kroon et al.
ATHEROSCLEROSIS (2000)
Share Paper
